CYMEVENE

This brand name is authorized in Austria, Australia, Brazil, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CYMEVENE contains one active pharmaceutical ingredient (API):

1 Ganciclovir
UNII 02L083W284 - GANCICLOVIR SODIUM

Ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl)guanine or DHPG, is a broadspectrum virustatic agent which inhibits the replication of viruses, including viruses of the herpes group, both in vivo and in vitro: herpes simplex types 1 and 2 (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes zoster (HZV).

Read about Ganciclovir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CYMEVENE Powder for concentrate for solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AB06 Ganciclovir J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10328N, 5749N, 6136Y
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 529201302152315
Country: EE Ravimiamet Identifier(s): 1022252, 1085228, 1825275, 1826276
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 58266
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 169557
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 43515
Country: HK Department of Health Drug Office Identifier(s): 60055
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3472
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1002130
Country: MT Medicines Authority Identifier(s): AA565/19902, AA729/00202
Country: NL Z-Index G-Standaard, PRK Identifier(s): 27065
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 5931
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100016430, 100257865, 100296256, 100310708, 100347090, 100425736
Country: SG Health Sciences Authority Identifier(s): 05051P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680979254059
Country: ZA Health Products Regulatory Authority Identifier(s): Y/20.2.8/291

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.